A new paper, entitled “Alzheimer disease biomarker testing in Cerebrospinal Fluid: a method to harmonize assay platforms in the absence of an absolute reference standard” was published by the founder in Clinical Chemistry.

 Read more . . .

A new publication, entitled “Comparison of two analytical platforms for the clinical qualification of Alzheimer’s disease biomarkers in pathologically-confirmed dementia”  was published in Journal of Alzheimer’s disease.

More on this publication.